Citation Impact
Citing Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Molecular Cloning and Characterization of an Aquaporin cDNA from Salivary, Lacrimal, and Respiratory Tissues
1995 StandoutNobel
A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)
2000
Nasopharyngeal carcinoma
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Current clinical outcomes demand new treatment options for SCCHN
2005
Conventional cancer therapy: promise broken or promise delayed?
1998
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
2004
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
2001
Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up
2004
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma
2004
Chemotherapy for small cell lung cancer
2003
Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck
2000
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication
1993
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: A critical review
2003
Nasopharyngeal carcinoma
2019 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
2010
Soft-Tissue Sarcomas in Adults
2005 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
2008 Standout
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
2005
Lung cancer: current therapies and new targeted treatments
2016 Standout
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
2002
Communicating sad, bad, and difficult news in medicine
2004 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?
2008
A phase II study of gemcitabine in patients with malignant pleural mesothelioma
1999
Nasopharyngeal carcinoma
2015 Standout
Novel agents and incremental advances in the treatment of head and neck cancer
2004
Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer
2002
Chemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma
2007
The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033
2002
Epidemiology, Staging, and Screening of Head and Neck Cancer
2006
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Chemotherapy for Malignant Pleural Mesothelioma
2003
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
State-of-the-art management of locally advanced head and neck cancer
2005
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Hyperthermia adds to chemotherapy
2008
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
1992
Head and Neck Cancer
1993 Standout
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
2004
Medical students' attitudes towards breaking bad news: an empirical test of the World Health Organization model
2001
Microtubules as a target for anticancer drugs
2004 Standout
Update on chemoradiotherapy for head and neck cancer
2002
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
Randomized Clinical Trials in Soft Tissue Sarcoma
2002
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
A Review of Chemotherapy Trials for Malignant Mesothelioma
1998
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Small-cell lung cancer
2005
Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community
2004
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
2002
Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?
1997
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
2002 Standout
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck
2004
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Clinical Perspectives on Platinum Resistance
2000
Altered Fractionation and/or Adjuvant Chemotherapy in Definitive Irradiation of Squamous Cell Carcinoma of the Head and Neck
2003
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
2000
Advances in Malignant Mesothelioma
2005 Standout
Head and Neck Cancer
2001 Standout
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Tumour stem cells and drug resistance
2005 Standout
Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer
2001
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Head and Neck Cancer
2020 Standout
Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy
2005
Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?
2005
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Claims of Equivalence in Medical Research: Are They Supported by the Evidence?
2000
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Medically inoperable lung carcinoma: The role of radiation therapy
1996
Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group
2005
Surfing the p53 network
2000 StandoutNature
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2003
Does Histologic Grade Have a Role in the Management of Head and Neck Cancers?
2001
Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2006
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
Works of A. Kirkpatrick being referenced
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
2001
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
1998
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck
1994
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
1993
High dose etoposide for brain metastases of small cell lung cancer. A phase II study
1989
Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (cDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the eortc lung cancer and radiotherapy cooperative groups
1990
A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer
1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial
1996
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
1992
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
1996 Standout
Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative group
1997
A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck
1992
Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC phase III trial 22931
2001
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck
1987
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase iii study of the eortc lung cancer cooperative group
1997